Table: Immuno Biological Lab -Q1 group results

Immuno-Biological Laboratories

06/08/2021 07:30

Aug 6 (Reuters)- 
             Immuno Biological Laboratories Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended        Year to  
                Jun 30, 2021        Jun 30, 2020      Mar 31, 2022  
                   LATEST             YEAR-AGO           LATEST     
                   RESULTS             RESULTS          FORECAST    
  Sales            125 mln             116 mln           770 mln    
                 (+7.3 pct)          (+2.9 pct)        (+27.7 pct)  
  Operating      loss 73 mln        loss 101 mln      loss 107 mln  
  Recurring     loss 101 mln        loss 127 mln      loss 154 mln  
  Net           loss 110 mln        loss 129 mln      loss 162 mln  
  EPS          loss 11.89 yen      loss 13.85 yen    loss 17.42 yen 
  Ann Div                                NIL               NIL      
  -Q2 div                                NIL               NIL      
  -Q4 div                                NIL               NIL      
  
  NOTE - Immuno Biological Laboratories Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4570.T